6030 Participants Needed

Healthcare Models for Postpartum Hypertension

Recruiting at 2 trial locations
RP
Overseen ByRafael Pérez-Escamilla, PhD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Yale University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to improve outcomes for new mothers experiencing postpartum hypertension and related mental health and heart issues. It will compare two healthcare approaches: a Remote Medical Model (also known as the Telehealth Model or Virtual Care Model) and a Community Health Model, against the usual care to determine which is more effective. Women who have recently given birth and are dealing with high blood pressure postpartum, especially those facing healthcare challenges, might find this trial suitable if they are in Connecticut, Massachusetts, or New York and have Medicaid or no insurance. As an unphased trial, this study offers a unique opportunity to contribute to healthcare improvements for postpartum women.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that the Remote Medical Model (RMM) for managing high blood pressure after childbirth receives positive feedback from patients. Studies indicate that monitoring blood pressure from home safely and effectively manages this condition. It helps detect ongoing high blood pressure early and ensures better follow-up care.

Similarly, the Community Health Model (CHM) has demonstrated promising safety results. This method combines home monitoring with local health resources and has been linked to fewer hospital visits and better adherence to medical advice for managing high blood pressure after childbirth. Both models aim to improve health outcomes while prioritizing patient safety.12345

Why are researchers excited about this trial?

Researchers are excited about the trial for postpartum hypertension because it explores innovative healthcare delivery models that could improve patient outcomes. Unlike standard care, which typically involves in-person visits and monitoring, the Remote Medical Model (RMM) adds a layer of remote monitoring and support, allowing for more frequent and convenient check-ins from home. The Community Health Model (CHM) builds on this by integrating community-based support and resources, offering a more holistic approach to managing hypertension. By comparing these models to the usual care, researchers hope to find out if these new methods can enhance patient engagement and control postpartum blood pressure more effectively.

What evidence suggests that this trial's treatments could be effective for postpartum hypertension?

This trial will compare different healthcare models for managing postpartum hypertension. Studies have shown that remote monitoring, as used in the Remote Medical Model (RMM) arm of this trial, greatly reduces the chances of new mothers being readmitted to the hospital for high blood pressure after childbirth. It also helps them adhere more closely to medical advice. Research indicates that the Community Health Model (CHM), another arm in this trial, which combines remote monitoring with local support, better controls blood pressure and identifies severe cases early. Evidence suggests that the Remote Medical Model improves patient satisfaction and care quality by allowing daily blood pressure checks at home. Both models show promise for managing high blood pressure after childbirth, reducing the risk of complications for new mothers. These methods focus on early detection and regular monitoring, which are crucial for preventing serious health issues.12456

Who Is on the Research Team?

RP

Rafael Pérez-Escamilla, PhD

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

This trial is for postpartum women who had a single live birth, speak English or Spanish, are on Medicaid or uninsured, and live in Connecticut, Massachusetts, or New York. They must be able to consent and not have severe medical conditions that interfere with participation. Women planning to move out of state soon or using illicit drugs cannot join.

Inclusion Criteria

You have recently given birth.
I am either uninsured or covered by Medicaid or its state equivalent.
You have given birth to one live baby (you may have had twins, but only one baby survived).
See 2 more

Exclusion Criteria

You have been diagnosed with a serious mental illness like schizophrenia or schizoaffective disorder.
My newborn is under someone else's care due to adoption or state involvement.
For participants without access to a phone, we will explore if there are options that will allow them to have access to a devise for the times when they need to communicate with the study team. If not, they will not be able to participate in the study since this study requires phone or telehealth communication with research staff and/or APPs, and CHWs depending on study phase.
See 12 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

During postpartum hospital stay
1 visit (in-person)

Standard of Care

Participants receive standard postpartum care and are provided with an Omron blood pressure cuff

6 weeks
Weekly follow-up (telehealth)

Remote Medical Model (RMM)

Participants receive remote monitoring with additional follow-up visits as needed for high blood pressure or mental health concerns

6-12 weeks
At least 1 visit per week (telehealth)

Community Health Model (CHM)

Incorporates community health workers/doulas providing postpartum hypertension support and mental health engagement

6 weeks
Weekly visits (hybrid: in-person and virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including blood pressure checks and mental health assessments

6 months
Assessments at 6 weeks, 3 months, and 6 months postpartum

What Are the Treatments Tested in This Trial?

Interventions

  • Community Health Model (CHM)
  • Remote Medical Model (RMM)
  • SoC
Trial Overview The study tests two healthcare delivery models aimed at early detection and management of postpartum hypertension against the standard care. One model uses remote monitoring (RMM), while the other involves community health approaches (CHM). The goal is to see which method improves clinical outcomes better.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Remote Medical Model (RMM)Experimental Treatment2 Interventions
Group II: Community Health Model (CHM)Experimental Treatment3 Interventions
Group III: Standard of Care (SoC)Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

Published Research Related to This Trial

The Patient Centered Medical Home (PCMH) model aims to enhance patient care by providing comprehensive, coordinated, and accessible services, which can lead to improved health outcomes and reduced healthcare costs.
The article offers a guide for implementing the PCMH model, emphasizing the use of evidence-based practices and clinical decision support tools to ensure high-quality care delivery.
Back to Basics: The Perioperative Surgical Home.Spruce, L.[2015]
The patient-centered medical home (PCMH) model enhances primary care by fostering partnerships among patients, families, and healthcare providers, aiming to deliver safe and high-quality care.
Home healthcare clinicians play a crucial role in the PCMH by connecting patients' home environments with primary care, which helps address comprehensive care needs and improves patient outcomes.
Understanding the patient-centered medical home.Moran, KJ., Burson, R.[2014]
A 60-day project at a Federally Qualified Health Center (FQHC) involving 22 patients with uncontrolled hypertension showed a statistically significant decline in mean blood pressure after implementing interprofessional collaboration (IPC) concepts, including a pharmacist education component.
Both care team members and patients reported increased satisfaction with the collaborative care process, indicating that enhancing the Patient Centered Medical Home (PCMH) model with IPC can improve patient outcomes in hypertension management.
Interprofessional Collaboration With Pharmacist-Driven Education for Hypertension Control in Federally Qualified Health Center Patients.Fury, S., Sparbel, K., Tadda, B.[2020]

Citations

Clinical Outcomes Associated With a Remote Postpartum ...Remote monitoring of postpartum hypertension was associated with fewer readmissions, increased adherence to national clinical guidelines, and ...
Status, outcome, and related factors of postpartum ...Hypertension prevalence 1 month post-delivery was 2.61% (86/3297). Among the 86 pregnant women, 32 (37.21 %) had persistent hypertension at four months post- ...
Advances in postpartum hypertension managementOne retrospective cohort study of outcomes after ambulatory BP monitoring at one year postpartum in 200 women with severe preeclampsia ...
Comprehensive Postpartum Management for Women With ...Secondary outcomes include blood pressure control at 7-10 days postpartum, identification and treatment of severe blood pressures, severe maternal morbidity, ...
Hypertension in Pregnancy and PostpartumData from the United States highlight favorable outcomes for postpartum HBPM compared with usual care.
Severe Hypertension In Pregnancy | AIMThe Severe Hypertension in Pregnancy patient safety bundle was revised in 2022 to incorporate respectful care concepts, revise existing elements, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security